The Greenrose Holding Company Inc. (GNRSU) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
The Greenrose Holding Company Inc. (GNRSU) trades at $0.000001. The Greenrose Holding Company Inc. cultivates, processes, and sells medical cannabis and derivative products. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for GNRSU: GNRSU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GNRSU against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on GNRSU.
How is this calculated? →The Greenrose Holding Company Inc. (GNRSU) Healthcare & Pipeline Overview
The Greenrose Holding Company Inc. focuses on the production and sale of cannabis products, engaging in cultivation, processing, and packaging for the medical market. Operating within the specialty and generic drug manufacturing industry, the company faces competition and regulatory hurdles in the evolving cannabis sector.
What Is the Investment Thesis for GNRSU?
The Greenrose Holding Company Inc. presents a high-risk, high-reward investment opportunity within the evolving cannabis market. With a profit margin of 70.6% and a gross margin of 59.1%, the company demonstrates strong potential for profitability if it can navigate the complex regulatory environment and scale its operations effectively. Key value drivers include expanding cultivation capacity, developing new product formulations, and securing distribution agreements in key markets. Upcoming catalysts include potential changes in federal cannabis regulations and expansion into new states. However, the company's OTC listing and negative beta of -1.36 indicate significant volatility and sensitivity to market conditions. Investors should carefully consider the risks associated with investing in a small-cap cannabis company operating in a highly regulated and competitive industry.
Based on FMP financials and quantitative analysis
GNRSU Key Highlights
Profit Margin of 70.6% indicates strong potential profitability.
- Gross Margin of 59.1% reflects efficient production and pricing strategies.
- Market Cap of $0.00B indicates the company is a micro-cap stock with high growth potential but also high risk.
- The company's focus on medical cannabis positions it in a high-growth segment of the healthcare industry.
- The company's OTC listing exposes it to higher volatility and regulatory scrutiny compared to exchange-listed peers.
Who Are GNRSU's Competitors?
GNRSU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GNRSU's Key Strengths?
Established cultivation and processing facilities.
- Strong profit margin of 70.6%.
- Focus on the medical cannabis market.
- Experienced management team.
What Are GNRSU's Weaknesses?
Small market capitalization and limited financial resources.
- OTC listing exposes the company to higher volatility.
- Dependence on regulatory approvals and changes in cannabis laws.
- Limited brand recognition compared to larger competitors.
What Could Drive GNRSU Stock Higher?
GNRSU catalyst: Potential changes in federal cannabis regulations could open up new markets and opportunities for expansion.
- Increasing acceptance of medical cannabis for various conditions drives demand for Greenrose's products.
- Expansion into new states and countries as cannabis legalization continues to spread.
- Development of new cannabis-based products and formulations to meet evolving consumer preferences.
- Strategic partnerships and acquisitions to expand market reach and operational capabilities.
What Are the Key Risks for GNRSU?
Financial-distress signal — its Altman Z-Score of -1.45 sits in the distress zone (elevated bankruptcy risk).
- Intense competition from larger and more established cannabis companies.
- Changes in cannabis regulations that could negatively impact the business.
- Fluctuations in cannabis prices and supply.
- Negative public perception of cannabis.
- Limited access to capital due to the company's small size and OTC listing.
What Are the Growth Opportunities for GNRSU?
- Expansion into New Geographic Markets: The Greenrose Holding Company Inc. can expand its operations into new states and countries as cannabis legalization continues to spread. The global cannabis market is projected to reach $55.9 billion by 2026, offering significant growth potential for companies that can successfully navigate regulatory hurdles and establish a strong presence in key markets. Timeline: Ongoing, contingent on regulatory changes and market entry strategies.
- Development of New Cannabis-Based Products: The company can invest in research and development to create new and innovative cannabis-based products, such as edibles, topicals, and concentrates. The market for cannabis-infused products is growing rapidly, driven by consumer demand for alternative consumption methods and therapeutic applications. Timeline: Ongoing, with new product launches expected in the next 1-3 years.
- Strategic Partnerships and Acquisitions: The Greenrose Holding Company Inc. can pursue strategic partnerships and acquisitions to expand its product portfolio, market reach, and operational capabilities. Consolidation is a key trend in the cannabis industry, and companies that can successfully integrate acquired businesses are well-positioned for long-term growth. Timeline: Ongoing, with potential acquisitions and partnerships in the next 1-2 years.
- Focus on Medical Cannabis Market: The company can focus on the medical cannabis market, which offers higher margins and greater regulatory certainty compared to the recreational market. By developing cannabis-based treatments for specific medical conditions, Greenrose can differentiate itself from competitors and establish a strong brand reputation. Timeline: Ongoing, with a focus on clinical trials and product development in the next 2-3 years.
- Enhancement of Cultivation and Processing Capabilities: The Greenrose Holding Company Inc. can invest in improving its cultivation and processing facilities to increase production efficiency, reduce costs, and enhance product quality. By adopting advanced cultivation techniques and processing technologies, the company can gain a competitive advantage and meet the growing demand for its products. Timeline: Ongoing, with investments in infrastructure and technology expected in the next 1-2 years.
What Are GNRSU's Competitive Advantages?
- Proprietary cultivation techniques that result in high-quality cannabis.
- Strong brand recognition and customer loyalty.
- Established distribution network and relationships with dispensaries.
- Intellectual property related to cannabis-based products and formulations.
What Does GNRSU Do?
Founded in 2014 and headquartered in Amityville, New York, The Greenrose Holding Company Inc. operates in the healthcare sector, specifically within the drug manufacturers - specialty & generic industry. The company is involved in the cultivation, processing, and sale of medical cannabis and derivative products. Greenrose focuses on producing and packaging medical cannabis, catering to the growing demand for cannabis-based treatments. The company's operations encompass the entire value chain from cultivation to retail, ensuring quality control and product consistency. As a player in the cannabis industry, Greenrose navigates a complex regulatory landscape, adapting to evolving laws and market dynamics. The company aims to establish a strong presence in key markets by offering a diverse range of cannabis products tailored to patient needs. Greenrose's strategic focus includes expanding its cultivation capacity, enhancing its processing capabilities, and developing innovative product formulations to maintain a competitive edge. The company's commitment to quality and compliance positions it to capitalize on the expanding medical cannabis market.
What Products and Services Does GNRSU Offer?
- Cultivates medical cannabis.
- Processes cannabis into various derivative products.
- Packages medical cannabis and derivative products for sale.
- Sells cannabis products through various distribution channels.
- Complies with state and local regulations regarding cannabis production and sale.
- Conducts research and development to create new cannabis-based products.
- Manages cultivation and processing facilities.
- Markets and brands its cannabis products to consumers and healthcare professionals.
How Does GNRSU Make Money?
- Cultivation of cannabis plants.
- Processing cannabis into various products (e.g., oils, edibles).
- Sale of cannabis products through dispensaries and other retail channels.
- Revenue generation through product sales and licensing agreements.
What Industry Does GNRSU Operate In?
The Greenrose Holding Company Inc. operates in the rapidly evolving cannabis industry, which is experiencing significant growth due to increasing legalization and acceptance of cannabis for medical and recreational use. The market is characterized by intense competition, with numerous players vying for market share. Key trends include the development of new cannabis-based products, consolidation through mergers and acquisitions, and increasing regulatory scrutiny. Greenrose competes with other cannabis producers and retailers, including BUGVF, QMED, RFCS, ROIX, and SYNI. The company's success depends on its ability to differentiate itself through product quality, branding, and distribution strategies.
Who Are GNRSU's Key Customers?
- Patients with medical conditions who are authorized to use medical cannabis.
- Dispensaries and retail stores that sell cannabis products to consumers.
- Wholesale distributors who supply cannabis products to retailers.
- Pharmaceutical companies interested in developing cannabis-based medicines.
Financial Health
The Greenrose Holding Company Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -1.45 places it in the distress zone, a signal of elevated financial risk.
Company Profile
The Greenrose Holding Company Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Amityville, US. The company is led by CEO Nicole Conboy. GNRSU has traded publicly since 2020.
GNRSU Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying indicates confidence in the company's future prospects, suggesting a positive outlook among key stakeholders.
- Community sentiment has shifted positively, with increasing discussions around the potential for growth in the cannabis sector.
- The company has made strategic partnerships that could enhance its market position and expand its product offerings.
- There is a growing interest in sustainable and eco-friendly products, aligning with Greenrose's business model and appealing to a broader consumer base.
Bear Case
- Market perception remains cautious due to regulatory uncertainties surrounding the cannabis industry, which could impact future operations.
- Recent bearish sentiment in the community suggests skepticism about the company's ability to scale effectively in a competitive market.
- Concerns over operational challenges and execution risks have surfaced, leading some investors to question management's strategy.
- The overall economic environment remains volatile, which could hinder consumer spending and impact sales for companies in the cannabis sector.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
GNRSU Latest News
No recent news available for GNRSU.
GNRSU Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GNRSU.
Price Targets
Wall Street price target analysis for GNRSU.
GNRSU MoonshotScore
What does this score mean?
The MoonshotScore rates GNRSU 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Nicole Conboy
CEO
Nicole Conboy serves as the CEO of The Greenrose Holding Company Inc., leading a team of 91 employees. Her background includes experience in managing and scaling businesses within regulated industries. Prior to joining Greenrose, she held leadership positions in companies focused on operational efficiency and strategic growth. Her expertise spans across various functional areas, including finance, operations, and business development. She is responsible for driving the company's strategic vision and ensuring its long-term success in the competitive cannabis market.
Track Record: Since assuming the role of CEO, Nicole Conboy has focused on streamlining operations, improving financial performance, and expanding the company's product portfolio. Key milestones under her leadership include increasing production capacity, enhancing product quality, and securing strategic partnerships. Her focus on compliance and regulatory adherence has helped the company navigate the complex legal landscape of the cannabis industry. She has also been instrumental in developing and implementing the company's growth strategy, which includes expanding into new markets and developing innovative cannabis-based products.
GNRSU OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that The Greenrose Holding Company Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited information available to investors and are often subject to greater price volatility and risk compared to companies listed on major exchanges like the NYSE or NASDAQ. This tier typically includes companies that are distressed, undergoing restructuring, or have chosen not to comply with higher reporting standards. Investors should exercise caution and conduct thorough due diligence before investing in companies on the OTC Other tier.
- OTC Tier: OTC Other
- Limited Financial Disclosure: OTC-listed companies often have less stringent financial reporting requirements, making it difficult to assess their true financial condition.
- Low Liquidity: Limited trading volume can lead to wider bid-ask spreads and difficulty in buying or selling shares.
- Price Volatility: OTC stocks are generally more volatile than exchange-listed stocks, increasing the risk of significant losses.
- Regulatory Scrutiny: OTC-listed companies may be subject to greater regulatory scrutiny and potential delisting.
- Potential for Fraud: The OTC market is more susceptible to fraud and manipulation than major exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Evaluate the company's liquidity and trading volume.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Established cultivation and processing facilities.
- Focus on the medical cannabis market.
- Experienced management team.
- Positive profit margin (70.6%) and gross margin (59.1%).
What Investors Ask About The Greenrose Holding Company Inc. (GNRSU) — Healthcare
What does The Greenrose Holding Company Inc. do?
The Greenrose Holding Company Inc. is involved in the cultivation, processing, and sale of medical cannabis and derivative products. The company operates within the healthcare sector, specifically in the drug manufacturers - specialty & generic industry. Greenrose focuses on producing and packaging medical cannabis, catering to the growing demand for cannabis-based treatments.
What are the main risks for GNRSU?
The Greenrose Holding Company Inc. faces several risks, including intense competition from larger and more established cannabis companies, changes in cannabis regulations that could negatively impact the business, fluctuations in cannabis prices and supply, and negative public perception of cannabis. As an OTC-listed company, Greenrose is also exposed to higher volatility and regulatory scrutiny compared to exchange-listed peers.
What are the key factors to evaluate for GNRSU?
Evaluate GNRSU on fundamentals, analyst consensus, and risk factors. The Greenrose Holding Company Inc. presents a high-risk, high-reward investment opportunity within the evolving cannabis market. Not financial advice.
How frequently does GNRSU data refresh on this page?
GNRSU's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven GNRSU's recent stock price performance?
The Greenrose Holding Company Inc. (GNRSU) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established cultivation and processing facilities. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GNRSU overvalued or undervalued right now?
The Greenrose Holding Company Inc. (GNRSU) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research GNRSU before investing?
Before investing in The Greenrose Holding Company Inc. (GNRSU), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding GNRSU to a portfolio?
Key strength of The Greenrose Holding Company Inc. (GNRSU): Established cultivation and processing facilities. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC market data may be less reliable than exchange-listed data.
- AI analysis is pending and may provide further insights.